N
FDa Drug Changes
May 16, 2012 07:47PM
Apr 29, 2012 07:22AM
Votrient Treating Advanced Soft-Tissue Sarcoma
It usually starts as a lump under the skin that doesn't hurt or cause any real symptoms. Soft-tissue sarcoma usually shows up on an arm or leg, and it's very treatable if caught early.
Apr 27, 2012 02:27PM
New Drug for Erectile Dysfunction
The medication Stendra (avanafil) has just been approved by the U.S. Food and Drug Administration to treat erectile dysfunction, the FDA announced today.
Mar 31, 2012 08:30PM
Ticagrelor Reduces Heart Events
Brilinta (ticagrelor), a blood thinner approved by the U.S. Food and Drug Administration last summer, has been found to not only reduce first time cardiovascular events, but also to lower recurrent heart events or deaths.
Mar 30, 2012 11:43AM
Byetta Approved for Use With Basal Insulin
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Mar 29, 2012 12:20PM
Janssen Therapeutics, Division of Janssen Products, LP, announced the U.S. Food and Drug Administration (FDA) has approved INTELENCE® (etravirine) to be administered in combination with other antiretroviral (ARV) medications.
Mar 27, 2012 09:04PM
FDA Green Lights Anemia Drug Omontys
U.S. Food and Drug Administration officials have approved Omontys (peginesatide), a drug administered through monthly injections to treat anemia in patients with chronic kidney disease.
Mar 09, 2012 09:46AM
Preemies Breathe Better With new Rx
Newborns who arrive early often face respiratory problems since their lungs may not yet be fully developed. A new drug approved by the FDA joins four others to treat these problems.
Mar 05, 2012 04:12PM
Merck Cholesterol Drug Delayed
Drugmaker Merck & Co. announced Monday that the U.S. Food and Drug Administration (FDA) did not approve its investigational combination cholesterol-lowering drug.
Feb 22, 2012 10:06PM
FDA Backs Weight Loss Drug Qnexa
A U.S. Food and Drug Administration panel has approved investigational diet drug Qnexa designed to treat obesity in adults. The panel had previously rejected the weight loss drug in 2010 based on safety concerns.
Feb 16, 2012 05:20AM
Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tafamidis meglumine, the company’s investigational, novel, oral therapy for the treatment of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP).
|
|
 |
 |
Privacy Policy Site Policies About Contact Us Pharmacy Affiliate Pharmacist Contributors Medical Advisory Board